Metamizole

CHEMBL461522 Phase 4 Aprovado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

311.4 g/mol

LogP

—

Phase

4

A non-opioid analgesic for severe pain, with rare agranulocytosis risk.

Peso Molecular

311,3600 g/mol

LogP

0,00

TPSA

89,50 Å²

Regra dos 5 de Lipinski

Aprovado

Áreas Terapêuticas

Pain Management Migraine Generalized Anxiety Disorder Infectious Disease Non-Alcoholic Fatty Liver Disease Stroke Obesity Gastroenterology Hypertension Chronic Pain

Mecanismo de Ação

Binds to mu (μ), kappa (κ), and/or delta (δ) opioid receptors in the central and peripheral nervous system, mimicking endogenous endorphins. Activation of these G-protein-coupled receptors inhibits pain signal transmission and modulates the emotional response to pain.

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Mecanismo

Binds to mu (μ), kappa (κ), and/or delta (δ) opioid receptors in the central and peripheral nervous system, mimicking endogenous endorphins. Activation of these G-protein-coupled receptors inhibits pain signal transmission …

Estrutura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

Cc1c(N(C)CS(=O)(=O)O)c(=O)n(-c2ccccc2)n1C

InChI

InChI=1S/C13H17N3O4S/c1-10-12(14(2)9-21(18,19)20)13(17)16(15(10)3)11-7-5-4-6-8-11/h4-8H,9H2,1-3H3,(H,18,19,20)

Molecular Formula

C13H17N3O4S

HBD / HBA

1 / 6

Ligações Rotacionáveis

4

Átomos Pesados

21

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

A non-opioid analgesic for severe pain, with rare agranulocytosis risk.

Binds to mu (μ), kappa (κ), and/or delta (δ) opioid receptors in the central and peripheral nervous system, mimicking endogenous endorphins. Activation of these G-protein-coupled receptors inhibits pain signal transmission and modulates the emotional response to pain.

Yes, Metamizole is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL461522. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 3111. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

PillFYI

Procura informações acessíveis para o paciente?

Metamizole no PillFYI

Estrutura

Dados Rápidos

Fórmula: C13H17N3O4S
Sinônimos: 2

Links Externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.